JP4217318B2 - 標的核酸の定量分析方法および装置 - Google Patents
標的核酸の定量分析方法および装置 Download PDFInfo
- Publication number
- JP4217318B2 JP4217318B2 JP34749398A JP34749398A JP4217318B2 JP 4217318 B2 JP4217318 B2 JP 4217318B2 JP 34749398 A JP34749398 A JP 34749398A JP 34749398 A JP34749398 A JP 34749398A JP 4217318 B2 JP4217318 B2 JP 4217318B2
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- molecule
- labeled
- measurement
- pcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims description 71
- 108020004707 nucleic acids Proteins 0.000 title claims description 69
- 102000039446 nucleic acids Human genes 0.000 title claims description 69
- 238000000034 method Methods 0.000 title claims description 65
- 238000004445 quantitative analysis Methods 0.000 title description 2
- 238000005259 measurement Methods 0.000 claims description 82
- 230000003321 amplification Effects 0.000 claims description 43
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 43
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 239000012085 test solution Substances 0.000 claims description 24
- 230000033001 locomotion Effects 0.000 claims description 21
- 239000000758 substrate Substances 0.000 claims description 20
- 238000005311 autocorrelation function Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 230000000007 visual effect Effects 0.000 claims description 10
- 238000011156 evaluation Methods 0.000 claims description 9
- 238000002372 labelling Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 7
- 230000007423 decrease Effects 0.000 claims description 3
- 230000008034 disappearance Effects 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 68
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 50
- 108020004414 DNA Proteins 0.000 description 48
- 239000000523 sample Substances 0.000 description 48
- 238000001514 detection method Methods 0.000 description 16
- 230000008569 process Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 230000003287 optical effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 238000011002 quantification Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 238000001502 gel electrophoresis Methods 0.000 description 8
- 239000002777 nucleoside Substances 0.000 description 8
- 238000004364 calculation method Methods 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 150000003833 nucleoside derivatives Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000006059 cover glass Substances 0.000 description 4
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 241000701959 Escherichia virus Lambda Species 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000001506 fluorescence spectroscopy Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 230000005653 Brownian motion process Effects 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- WZSUOQDIYKMPMT-UHFFFAOYSA-N argon krypton Chemical compound [Ar].[Kr] WZSUOQDIYKMPMT-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000005537 brownian motion Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- UIZLQMLDSWKZGC-UHFFFAOYSA-N cadmium helium Chemical compound [He].[Cd] UIZLQMLDSWKZGC-UHFFFAOYSA-N 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000475 fluorescence cross-correlation spectroscopy Methods 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000001579 optical reflectometry Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34749398A JP4217318B2 (ja) | 1998-12-07 | 1998-12-07 | 標的核酸の定量分析方法および装置 |
| US09/325,189 US7115365B2 (en) | 1998-12-07 | 1999-06-03 | Method of analyzing a target nucleic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34749398A JP4217318B2 (ja) | 1998-12-07 | 1998-12-07 | 標的核酸の定量分析方法および装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000166598A JP2000166598A (ja) | 2000-06-20 |
| JP2000166598A5 JP2000166598A5 (cg-RX-API-DMAC7.html) | 2006-02-23 |
| JP4217318B2 true JP4217318B2 (ja) | 2009-01-28 |
Family
ID=18390606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP34749398A Expired - Fee Related JP4217318B2 (ja) | 1998-12-07 | 1998-12-07 | 標的核酸の定量分析方法および装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4217318B2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230090926A1 (en) * | 2020-02-21 | 2023-03-23 | Sekisui Medical Co., Ltd. | Method for detecting target nucleic acid using dried blood filter paper piece |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4589480B2 (ja) * | 2000-03-30 | 2010-12-01 | オリンパス株式会社 | 反復配列の多型を分析する方法 |
| JP4749622B2 (ja) * | 2001-08-10 | 2011-08-17 | オリンパス株式会社 | Ｄｎａエンドヌクレアーゼ活性の検出法 |
| US7081339B2 (en) * | 2002-04-12 | 2006-07-25 | Primera Biosystems, Inc. | Methods for variation detection |
| EP1925930A1 (en) | 2003-02-13 | 2008-05-28 | Hamamatsu Photonics K.K. | Flourescence correlation spectroscopy analyser |
| JP4227817B2 (ja) | 2003-02-28 | 2009-02-18 | 株式会社リコー | 画像形成装置 |
| JP4993260B2 (ja) * | 2006-05-15 | 2012-08-08 | 石川県 | 遺伝子定量装置及び定量方法 |
| JP6590244B2 (ja) * | 2015-05-20 | 2019-10-16 | 国立研究開発法人産業技術総合研究所 | 値付けされた物質量濃度標準物質の製造方法 |
-
1998
- 1998-12-07 JP JP34749398A patent/JP4217318B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230090926A1 (en) * | 2020-02-21 | 2023-03-23 | Sekisui Medical Co., Ltd. | Method for detecting target nucleic acid using dried blood filter paper piece |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000166598A (ja) | 2000-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7115365B2 (en) | Method of analyzing a target nucleic acid | |
| US8831887B2 (en) | Absolute PCR quantification | |
| US6376177B1 (en) | Apparatus and method for the analysis of nucleic acids hybridization on high density NA chips | |
| Fried et al. | Optical nanopore sensors for quantitative analysis | |
| JP4288175B2 (ja) | アレイ法を実施するための反応容器 | |
| EP2765424A1 (en) | Method for analyzing biomolecules and biomolecule analyzer | |
| Shin et al. | Analytical techniques for nucleic acid and protein detection with single-molecule sensitivity | |
| JP2005295877A (ja) | 核酸分析方法、分析装置及び分析用ディスク | |
| JP2010506583A (ja) | 核酸の増幅及び検出装置 | |
| JPWO2011068088A1 (ja) | ２次元ｃＤＮＡライブラリを用いた遺伝子発現解析方法 | |
| US20080076133A1 (en) | Method for determining polymorphism | |
| JP2004530137A (ja) | 検出法における光学的回折要素の使用 | |
| JP2001269196A (ja) | 被検体核酸の定量方法、および被検体核酸の分子数の計数方法 | |
| JP2025028990A (ja) | Ｄｎａ検出方法およびｄｎａ検出システム | |
| Wang et al. | An integrated digital PCR system with high universality and low cost for nucleic acid detection | |
| JP4262336B2 (ja) | 標的核酸の定量分析方法 | |
| JP2000166598A (ja) | 標的核酸の定量分析方法および装置 | |
| JP2004520052A5 (cg-RX-API-DMAC7.html) | ||
| US11091803B2 (en) | Nucleic acid quantification method | |
| JP6374967B2 (ja) | 多孔質基材における核酸増幅の検出 | |
| JP2000228999A (ja) | 個体の集団の多重遺伝子型 | |
| JP3910000B2 (ja) | １塩基置換検出方法 | |
| CN101903761B (zh) | 检测系统和方法 | |
| JP2004187607A (ja) | 核酸増幅産物に関する情報を得る方法 | |
| JP2000166599A (ja) | 標的核酸の定量分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051207 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051207 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20051207 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20051207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080722 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080919 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20081021 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20081110 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111114 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111114 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131114 Year of fee payment: 5 |
|
| LAPS | Cancellation because of no payment of annual fees |